drugs for low-income uninsured New Yorkers. &nbsp; To this end, the following seven PAPs were examined: <br>
              &nbsp;&bull; Astra Zeneca <br>
                &nbsp; &bull; Abbott <br>
                &nbsp; &bull; Pfizer <br>
                &nbsp; &bull; Pharmacia <br>
                &nbsp; &bull; Bristol Myers Squibb <br>
                &nbsp; &bull; Merck <br>
                &nbsp; &bull; Schering-Plough <br>
                <br>
                These PAPs were chosen because they offer th